Literature DB >> 2955844

A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro.

T L Jansen, A H Morice, M J Brown.   

Abstract

Noradrenaline preconstricted pulmonary and renal artery segments from 20 large White pigs were examined in vitro for their responses to alpha-human atrial natriuretic peptide (alpha-hANP), rat-atriopeptin I (AP I) or rat-atriopeptin III (AP III) added in a cumulative manner. The role of the vascular endothelium in atrial peptide-induced relaxation was examined in the presence of indomethacin and propranolol by removal of the endothelium in one of a pair of arterial segments. Pulmonary artery was significantly (P less than 0.001) more sensitive than renal artery to alpha-hANP with a potency ratio of approximately 10. alpha-hANP appeared to be a more potent relaxant than AP III and AP I in pulmonary artery. Potency ratios were approximately 2 (AP III vs alpha-hANP; P less than 0.05) and 30 (API vs alpha-ANP; P less than 0.001). Removal of the endothelium increased the sensitivity of renal artery to a alpha-hANP, but made no difference to the pulmonary arterial relaxations. In man the highest circulating concentrations of ANP are found in the pulmonary artery. The demonstration of its potent relaxant effects at this site in the pig indicates a possible role in the modulation of pulmonary arterial tone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955844      PMCID: PMC1853543          DOI: 10.1111/j.1476-5381.1987.tb11263.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP).

Authors:  K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1984-01-13       Impact factor: 3.575

2.  Synthesis of atrial natriuretic peptides and studies on structural factors in tissue specificity.

Authors:  M Sugiyama; H Fukumi; R T Grammer; K S Misono; Y Yabe; Y Morisawa; T Inagami
Journal:  Biochem Biophys Res Commun       Date:  1984-08-30       Impact factor: 3.575

3.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

4.  Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.

Authors:  R M Rapoport; F Murad
Journal:  Circ Res       Date:  1983-03       Impact factor: 17.367

5.  Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity.

Authors:  K S Misono; H Fukumi; R T Grammer; T Inagami
Journal:  Biochem Biophys Res Commun       Date:  1984-03-15       Impact factor: 3.575

6.  An atrial peptide is a potent renal vasodilator substance.

Authors:  T Oshima; M G Currie; D M Geller; P Needleman
Journal:  Circ Res       Date:  1984-05       Impact factor: 17.367

7.  Atriopeptins: a family of potent biologically active peptides derived from mammalian atria.

Authors:  D M Geller; M G Currie; K Wakitani; B R Cole; S P Adams; K F Fok; N R Siegel; S R Eubanks; G R Galluppi; P Needleman
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

8.  Identification in rat atrial tissue of multiple forms of natriuretic polypeptides of about 3,000 daltons.

Authors:  K Kangawa; A Fukuda; I Kubota; Y Hayashi; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1984-06-15       Impact factor: 3.575

9.  Vasodilator profile of synthetic atrial natriuretic factor.

Authors:  R J Winquist; E P Faison; R F Nutt
Journal:  Eur J Pharmacol       Date:  1984-06-15       Impact factor: 4.432

Review 10.  Endothelial cells as mediators of vasodilation of arteries.

Authors:  R F Furchgott; P D Cherry; J V Zawadzki; D Jothianandan
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

View more
  8 in total

1.  Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

Authors:  H Jin; R H Yang; Y F Chen; R M Jackson; S Oparil
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Hemodynamic and humoral effects of atrial natriuretic peptide on pulmonary circulation after cardiac surgery.

Authors:  Keisuke Morimoto; Iwao Taniguchi; Shigeto Miyasaka; Shingo Ishiguro; Shigetsugu Ohgi
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

3.  Haemodynamic effects of atrial natriuretic peptide in hypoxic chronic obstructive pulmonary disease.

Authors:  T K Rogers; W Sheedy; J Waterhouse; P Howard; A H Morice
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

Review 4.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

Review 5.  The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

6.  Atrial natriuretic peptide concentrations in children with pulmonary hypertension: correlation with hemodynamic measurements.

Authors:  F S Tunaoglu; F R Olgunturk; N Gokcora; C Turkyilmaz; F Gurbuz
Journal:  Pediatr Cardiol       Date:  1994 Nov-Dec       Impact factor: 1.655

7.  Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.

Authors:  S Adnot; P Andrivet; P E Chabrier; J Piquet; P Plas; P Braquet; F Roudot-Thoraval; C Brun-Buisson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.

Authors:  J S Thompson; W Sheedy; A H Morice
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.